THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) will webcast its investor meeting at the upcoming American Society of Clinical Oncology (ASCO) Conference on Sunday, June 1 at 8 p.m. Central Time. Members of Amgen’s scientific and management team will participate at the meeting. The company plans to highlight key compounds in its pipeline, including denosumab.
